Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Carcinoembryonic antigen peptide

Copy Product Info
🥰Excellent
Catalog No. TP1286Cas No. 168635-85-6
Alias CEA peptide

Carcinoembryonic antigen peptide 1 (CEA peptide) is a Carcinoembryonic Antigen (CEA) derived peptide, of which sequen is YLSGANLNL. CEA is a broad-spectrum tumour marker, a glycoprotein produced by colorectal cancer tissues, which acts as an antigen to elicit an immune response.

Carcinoembryonic antigen peptide

Carcinoembryonic antigen peptide

Copy Product Info
🥰Excellent
Catalog No. TP1286Alias CEA peptideCas No. 168635-85-6
Carcinoembryonic antigen peptide 1 (CEA peptide) is a Carcinoembryonic Antigen (CEA) derived peptide, of which sequen is YLSGANLNL. CEA is a broad-spectrum tumour marker, a glycoprotein produced by colorectal cancer tissues, which acts as an antigen to elicit an immune response.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$98In StockIn Stock
5 mg$297In StockIn Stock
10 mg$443In StockIn Stock
25 mg$718In StockIn Stock
50 mg$987In StockIn Stock
100 mg$1,330In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Carcinoembryonic antigen peptide 1 (CEA peptide) is a Carcinoembryonic Antigen (CEA) derived peptide, of which sequen is YLSGANLNL. CEA is a broad-spectrum tumour marker, a glycoprotein produced by colorectal cancer tissues, which acts as an antigen to elicit an immune response.
In vitro
Carcinoembryonic Antigen (CEA) serves as a tumor marker for lung cancer and is utilized for both prognostic and predictive purposes. As a glycoprotein that plays a role in cell adhesion, CEA is typically produced during fetal development, with its production ceasing before birth. It is a glycosyl phosphatidyl inositol (GPI)-anchored cell surface glycoprotein, with its sialofucosylated glycoforms functioning as colon carcinoma L-selectin and E-selectin ligands. This characteristic is crucial for the potential metastatic spread of colon carcinoma cells.
SynonymsCEA peptide
Chemical Properties
Molecular Weight964.07
FormulaC43H69N11O14
Cas No.168635-85-6
SmilesCC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O
Relative Density.1.289 g/cm3 (Predicted)
SequenceTyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu
Sequence ShortYLSGANLNL
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mM, Sonication is recommended.
H2O: 10 mg/mL (10.37 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM1.0373 mL5.1863 mL10.3727 mL51.8635 mL
5 mM0.2075 mL1.0373 mL2.0745 mL10.3727 mL
10 mM0.1037 mL0.5186 mL1.0373 mL5.1863 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Carcinoembryonic antigen peptide | purchase Carcinoembryonic antigen peptide | Carcinoembryonic antigen peptide cost | order Carcinoembryonic antigen peptide | Carcinoembryonic antigen peptide chemical structure | Carcinoembryonic antigen peptide in vitro | Carcinoembryonic antigen peptide formula | Carcinoembryonic antigen peptide molecular weight